BRCA1 MUTATION
Clinical trials for BRCA1 MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRCA1 MUTATION trials appear
Sign up with your email to follow new studies for BRCA1 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for BRCA breast cancer: triple-drug combo shows promise in early trial
Disease control CompletedThis early-phase trial tested a combination of three drugs—olaparib, palbociclib, and fulvestrant—in 9 people with advanced, hormone receptor-positive breast cancer who also have BRCA1 or BRCA2 mutations. The main goal was to see if the combination is safe and to measure how long…
Matched conditions: BRCA1 MUTATION
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Toolkit may help families share cancer risk information
Knowledge-focused CompletedThis study looked at whether a special toolkit helps people with BRCA gene mutations tell their relatives about their genetic test results. Researchers wanted to see if using the toolkit makes it more likely that at-risk family members will get tested themselves. The study involv…
Matched conditions: BRCA1 MUTATION
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 26, 2026 04:36 UTC